Part,  Chapter, Paragraph

  1    I,     2. 10.  2   |             animal health, veterinary drugs, pesticides and plant health.~ ~
  2    I,     2. 10.  2   |      bioseparations and as vectors of drugs, bioactive molecules and
  3    I,     2. 10.  4   |            for each and every pack of drugs or medical device, which
  4    I,     2. 10.  4   |             unique identification for drugs or medical device, where
  5    I,     2. 10.  4   |              worst case, two packs of drugs with the same serial number
  6   II,     4.  1       |               consumption of alcohol, drugs and tobacco and reducing
  7   II,     5.  1.  1   |       patients exposed to nephrotoxic drugs are at higher risk for CKD.
  8   II,     5.  1.  2   |           pharmaceutical industry and drugs, but these diagnostic and
  9   II,     5.  2.  3   |            care setting: thrombolytic drugs, PTCA and CABG. Given the
 10   II,     5.  2.  5   |        pharmacological treatment with drugs must be considered.~For
 11   II,     5.  2.  6   |           various hypocholesterolemic drugs have definitively shown,
 12   II,     5.  2.  6   |               and the availability of drugs able to inhibit cholesterol
 13   II,     5.  2.  6   |            association of two or more drugs is often necessary to achieve
 14   II,     5.  3.  2   |              patient access to cancer drugs by Karolinska Institute
 15   II,     5.  3.  2   |            availability of new cancer drugs. See: http://annonc.oxfordjournals.
 16   II,     5.  3.  7   |         increasing cost of anticancer drugs and devices is an important
 17   II,     5.  3.  7   |      countries. The use of anticancer drugs should be restricted to
 18   II,     5.  3.  7   |              patient access to cancer drugs” (Jonsson et al, 2007) highlights
 19   II,     5.  3.  7   |              of new innovative cancer drugs through the competent authorities.~·
 20   II,     5.  3.  7   |             for new innovative cancer drugs is available for the health
 21   II,     5.  3.  7   |             to develop new innovative drugs, it comes to the health
 22   II,     5.  3.  7   |             system to integrate these drugs into therapy programs. It
 23   II,     5.  3.  7   |              toxicity for most of the drugs.~· With respect to pricing,
 24   II,     5.  3.  7   |       purchasing power. Secondly, new drugs are often launched in a
 25   II,     5.  3.  7   |          phase. For example, many new drugs have been introduced in
 26   II,     5.  5.Int   |            mood altering psychotropic drugs. Men are more likely to
 27   II,     5.  5.Int   |               addressed the misuse of drugs and the harm caused by alcohol.
 28   II,     5.  5.  3   |             schizophrenia since these drugs are applied also to treat
 29   II,     5.  5.  3   |           there is a need to identify drugs that may have favourable
 30   II,     5.  5.  3   |             development of innovative drugs.~The social situation –
 31   II,     5.  5.  3   |      including the development of new drugs, since prevention will hopefully
 32   II,     5.  5.  3   |              generation antipsychotic drugs recommended by international
 33   II,     5.  5.  3   |       second-generation antipsychotic drugs (Kahn et al, 2008). Non-compliance
 34   II,     5.  5.  3   |          three essential psychotropic drugs – an antidepressant, an
 35   II,     5.  5.  3   |               treatment, psychotropic drugs and mental health workers.
 36   II,     5.  5.  3   |        Effectiveness of antipsychotic drugs in first-episode schizophrenia
 37   II,     5.  5.  3   |               receiving antiepileptic drugs (AEDs)(Commission, 1993).
 38   II,     5.  5.  3   |             two or more antiepileptic drugs and one or more seizures
 39   II,     5.  5.  3   |           months Ban in people taking drugs contraindicated~ with driving~
 40   II,     5.  5.  3   |                    Norway I 12 months Drugs stolen or last seizure in
 41   II,     5.  5.  3   |          driving;~AED = Antiepileptic drugs; EEG = Electroencephalogram.~ ~ ~ ~
 42   II,     5.  5.  3   |            cure for MS, but there are drugs able to slow down the underlying
 43   II,     5.  5.  3   |               administration of these drugs (injections and up to every
 44   II,     5.  5.  3   |       potential side effects of these drugs is critical for the patients
 45   II,     5.  5.  3   |              ensure compliance. Other drugs are used, such as azathioprine,
 46   II,     5.  5.  3   |         cyclophosphamide. A number of drugs are being tested some of
 47   II,     5.  5.  3   |               of Parkinson’s disease. Drugs Aging 23(9):693-721.~Eichhorn
 48   II,     5.  6.Acr   |          anti-inflammatory analgesics drugs~OA~Osteoarthritis~RA~Rheumatoid
 49   II,     5.  6.  3   |            with new disease modifying drugs, better pain management
 50   II,     5.  7.  4   |       patients exposed to nephrotoxic drugs are at higher risk for CKD.~ ~
 51   II,     5.  7.  5   |              example when nephrotoxic drugs should be used for the treatment
 52   II,     5.  8.  3   |              ambulatory care, 2.7 for drugs, 2.9 for inpatient care
 53   II,     5.  9.  3   |               providers. Antiallergic drugs should be evaluated in terms
 54   II,     5.  9.  3   |      ambulatory care (€ 3.8 billion), drugs (€ 3.6 billion) and inpatient
 55   II,     5.  9.  5   |            targets.~New anti-allergic drugs should be evaluated in terms
 56   II,     5. 15.Acr   |              Rare Disorders~OD~Orphan Drugs~RD~Rare Diseases~ ~
 57   II,     5. 15.  3   |        available data concerns Orphan Drugs (OD), drugs developed for
 58   II,     5. 15.  3   |           concerns Orphan Drugs (OD), drugs developed for a rare condition.
 59   II,     5. 15.  3   |          study on the price of orphan drugs (OD). The study, conducted
 60   II,     5. 15.  3   |          looks at the price of orphan drugs authorised in the EU and
 61   II,     5. 15.  3   |               on the access to orphan drugs in Europe (dates of national
 62   II,     5. 15.  3   |             not respected, and orphan drugs are made available in a
 63   II,     5. 15.  3   |            worse than those for other drugs, although they are intended
 64   II,     5. 15.  4   |              in discussions on orphan drugs.~ ~DG Public Health established
 65   II,     5. 15.  6   |                2004): Study on Orphan Drugs. Published 16/11/04. Available
 66   II,     5. 15.  6   |             approach to reviewing new drugs condemning the victims of
 67   II,     5. 15.  6   |            challenges posed by orphan drugs. Int J Technol Assess Health
 68   II,     5. 15.  6   |                2006): Adopting orphan drugs -- two dozen years of treating
 69   II,     5. 15.  6   |          budgets for expensive orphan drugs: Gaucher disease in Israel
 70   II,     5. 15.  6   |             Tsuchiya A (2005): Orphan drugs and the NHS: should we value
 71   II,     5. 15.  6   |              rare diseases and orphan drugs. Available at: htt et~Van
 72   II,     5. 15.  6   |              rare diseases and orphan drugs. J Intern Med. 2006; 260(
 73   II,     6.  4.  3   |               vaccines and anti-viral drugs.~ ~The Commission also supports
 74   II,     6.  4.  3   |           both vaccines and antiviral drugs.~ ~
 75   II,     9           |      potential dangers of therapeutic drugs taken during early pregnancy.
 76   II,     9           |          early pregnancy. A number of drugs are now known to be teratogenic (
 77   II,     9           |      necessary (such as antiepileptic drugs) but a careful selection
 78   II,     9           |         postmarketing surveillance of drugs taken during pregnancy is
 79   II,     9           |          possible that there are more drugs currently on the market
 80   II,     9           |              research.~ ~Recreational drugs such as cocaine and solvent
 81   II,     9           |               data). Looking at other drugs also brings Estonia, Germany,
 82   II,     9.  1.  2   |      potential dangers of therapeutic drugs taken during early pregnancy.
 83   II,     9.  1.  2   |          early pregnancy. A number of drugs are now known to be teratogenic (
 84   II,     9.  1.  2   |      necessary (such as antiepileptic drugs) but a careful selection
 85   II,     9.  1.  2   |         postmarketing surveillance of drugs taken during pregnancy is
 86   II,     9.  1.  2   |          possible that there are more drugs currently on the market
 87   II,     9.  1.  2   |              research.~ ~Recreational drugs such as cocaine and solvent
 88   II,     9.  1.  2   |              as alcohol, recreational drugs, smoking and obesity, are
 89   II,     9.  1.  2   |     systematic follow-up of medicinal drugs and assisted reproduction
 90   II,     9.  1.  2   |           Scialli A, Peters P (2001): Drugs during pregnancy and lactation:
 91   II,     9.  1.  2   |              handbook of prescription drugs and comparative risk assessment.
 92   II,     9.  2.  2   |          Project on Alcohol and Other Drugs (ESPAD): This is an important (
 93   II,     9.  2.  2   |           alcohol, tobacco, and other drugs. Its web site provides considerable
 94   II,     9.  2.  4   |               data). Looking at other drugs also brings Estonia, Germany,
 95   II,     9.  3.  1   |            mood altering psychotropic drugs. Men are more likely to
 96   II,     9.  3.  1   |           there are new bone-specific drugs and broad-spectrum drugs
 97   II,     9.  3.  1   |              drugs and broad-spectrum drugs that combat osteoporosis
 98   II,     9.  3.  1   |          dysfunctional conditions, or drugs. Dysfunctional uterine bleeding
 99   II,     9.  3.  1   |         prescription and recreational drugs implicated. Moreover, it
100   II,     9.  3.  1   |             and previous diseases and drugs taken should then be considered.
101   II,     9.  3.  3   |               as alcohol consumption, drugs and substance abuse and
102   II,     9.  4.  3   |          prescription of psychotropic drugs and safe housing (European
103   II,     9.  5.  2   |          framework (Cancer, HIV/AIDS, Drugs, health promotion, Health
104   II,     9.  5.  3   |            mood altering psychotropic drugs. The disability associated
105  III,    10.  1.  3   |          Chermack ST (1993): Alcohol, drugs and human physical aggression.
106  III,    10.  2.  1   |           alcohol, homicides, illegal drugs, suicides and fires combined.~ ~
107  III,    10.  2.  1   |         ambulatory care, prescription drugs, home health care and nursing
108  III,    10.  2.  1   |      pharmacotherapy includes several drugs from different categories.
109  III,    10.  2.  1   |            They are both prescription drugs approved by national authorities
110  III,    10.  2.  1   |        Driving under the influence of drugs, alcohol and medicine~ECAS~
111  III,    10.  2.  1   |          Project on Alcohol and Other Drugs~FAO~Food and Agriculture
112  III,    10.  2.  1   |          Project on Alcohol and Other Drugs (ESPAD; part-financed by
113  III,    10.  2.  1   |          Project on Alcohol and Other Drugs (ESPAD) found that the average
114  III,    10.  2.  1   |      childhood abuse and use of other drugs in addition to alcohol are
115  III,    10.  2.  1   |            Driving under influence of drugs, alcohol and medicine~http ~ ~
116  III,    10.  2.  1   |         Nordic Studies on Alcohol and Drugs 20 25-40.~ ~Kristenson H,
117  III,    10.  2.  1   |                             10.2.1.3. Drugs and substance misuse1~ ~
118  III,    10.  2.  1(1)|                    Non-medical use of drugs that have been classified
119  III,    10.  2.  1(1)|         Single Convention on Narcotic Drugs (as amended in 1972) and
120  III,    10.  2.  1(1)|               as amended in 1972) and drugs placed under international
121  III,    10.  2.  1   |        European Monitoring Centre for Drugs and Drug Addiction~ESPAD~
122  III,    10.  2.  1   |          Project on Alcohol and Other Drugs~HBSC~Health Behaviour among
123  III,    10.  2.  1   |       European Information Network on Drugs and Drug Addiction~TDI~Treatment
124  III,    10.  2.  1   |             other - often synthetic - drugs are also sometimes used.
125  III,    10.  2.  1   |           cocaine and other stimulant drugs by socially integrated individuals
126  III,    10.  2.  1   |              of administration of the drugs are, depending on the physical
127  III,    10.  2.  1   |              long term use of illicit drugs. The social situation of
128  III,    10.  2.  1   |        European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)
129  III,    10.  2.  1   |              the most frequently used drugs among the general population
130  III,    10.  2.  1   |         numbers of users of different drugs in the European Union and
131  III,    10.  2.  1   |            last year use of different drugs shows that more than 10%
132  III,    10.  2.  1   |             drug use~ ~Use of illicit drugs can begin as early as in
133  III,    10.  2.  1   |        prevalence of the use of other drugs has also occurred.~ ~Figure
134  III,    10.  2.  1   |        problems related to the use of drugs (Table 10.2.1.3.2).~ ~Table
135  III,    10.  2.  1   |        although they may inject other drugs as well. Some countries
136  III,    10.  2.  1   |            consumption of one or more drugs and that occur, generally,
137  III,    10.  2.  1   |          heroin clients among all new drugs clients seeking treatment
138  III,    10.  2.  1   |              use.~ ~Historically, the drugs debate has been polarised
139  III,    10.  2.  1   |              consumption of stimulant drugs such as cocaine by well
140  III,    10.  2.  1   |              the misuse of prescribed drugs (opioids, benzodiazepines
141  III,    10.  2.  1   |         source of both information on drugs and as a means for promoting
142  III,    10.  2.  1   |            alternatives to prohibited drugs on the other. This problem
143  III,    10.  2.  1   |        European Monitoring Centre for Drugs and Drug Addiction (EMCDDA),
144  III,    10.  2.  1   |        European Monitoring Centre for Drugs and Drug Addiction (EMCDDA).
145  III,    10.  2.  1   |          Project on Alcohol and Other Drugs (ESPAD) (2003): Psychoactive
146  III,    10.  2.  2   |           well as the availability of drugs able to inhibit cholesterol
147  III,    10.  2.  4   |              Rare Diseases and Orphan Drugs~PHG~Public Health Genomics~
148  III,    10.  2.  4   |         variants on the metabolism of drugs and the development of drug
149  III,    10.  2.  4   |              negative side-effects of drugs as physicians and policy
150  III,    10.  2.  4   |             look at the metabolism of drugs and the impact of the CYP
151  III,    10.  3.  2   |              electronics, anti-cancer drugs (Pt), catalysts in various
152  III,    10.  3.  4   |             floods and no shortage of drugs or vaccines was reported.
153  III,    10.  5.  3   |              for addictions (alcohol, drugs).~ ~Impact of work on mortality,
154  III,    10.  6.  2   |             society free from illicit drugs and doping, and a reduction
155   IV,    11.  1.  5   |      Preventable adverse reactions to drugs are claimed to be the single
156   IV,    11.  1.  5   |         administration of intravenous drugs (Taxis and Barber, 2003).
157   IV,    11.  3.  2   |     prescription and over-the-counter drugs, with the latter that normally
158   IV,    11.  3.  2   |            average or median price of drugs with similar pharmacotherapeutic
159   IV,    11.  3.  2   |              for limiting spending on drugs is currently exclusively
160   IV,    11.  3.  2   |              to reimburse the cost of drugs to the insurance beneficiaries
161   IV,    11.  3.  2   |             of less expensive generic drugs for brand name drugs once
162   IV,    11.  3.  2   |          generic drugs for brand name drugs once the pharmaceutical
163   IV,    11.  3.  2   |           Policies to promote generic drugs are prevalent in Europe,
164   IV,    11.  3.  2   |              11.4. Relative prices of drugs across EU25 based on price
165   IV,    11.  5.  6   |            specific immunosuppressive drugs, and the experience acquired
166   IV,    11.  6.  2   |              sharing for prescription drugs leads to worse health outcomes,
167   IV,    11.  6.  2   |               al, 2003). Prescription drugs may have cost sharing in
168   IV,    11.  6.  2   |             full cost of prescription drugs up to an out-of-pocket maximum.
169   IV,    11.  6.  5   |              sharing for prescription drugs: implications for equity
170   IV,    12.  2       |        pharmacological treatment with drugs must be considered.~ ~Finland
171   IV,    12.  2       |      pharmacotherapy includes several drugs from different categories.
172   IV,    12.  2       |            They are both prescription drugs approved by national authorities
173   IV,    12.  2       |            Driving under influence of drugs, alcohol and medicine~http
174   IV,    12.  4       |             and services.~JLS~Illegal Drugs; Immigration policy and
175   IV,    12.  4       |        European Monitoring Centre for Drugs and Drug Addiction (Lisbon,
176   IV,    12.  4       |             European level concerning drugs and drug addiction and their
177   IV,    12.  4       |         management of migration flows~Drugs Prevention and Information
178   IV,    12.  5       |             tobacco, alcohol, illegal drugs and pharmaceuticals used
179   IV,    12. 10       | Physical activity~High ~Regional~ Yes~Drugs and substance abuse~High ~
180   IV,    12. 10       |               AGAINST OBESITY~http df~Drugs and substance abuse~ high~ ~
181   IV,    12. 10       |               ability to say “no’” to drugs including alcohol~Project “
182   IV,    12. 10       | Sportstättenbauförderung, see www. ~ ~Drugs and substance abuse~High
183   IV,    12. 10       |             framework in reference to drugs and substance abuse consists
184   IV,    12. 10       |         concerning different sorts of drugs (e. g. “Quit the shit”-program
185   IV,    12. 10       |            the consumption of illegal drugs (Project supported by Federal
186   IV,    12. 10       |              of (ex-)users of illegal drugs in co-operation with German
187   IV,    12. 10       |              further information seeDrugs and Addiction Report” of
188   IV,    12. 10       |                 Federal Institute for Drugs and Medical Devices (Bundesinstitut
189   IV,    12. 10       |            animal feed and veterinary drugs, tobacco products, plant
190   IV,    12. 10       |            animal feed and veterinary drugs, tobacco products, plant
191   IV,    12. 10       |             see Federal Institute for Drugs and Medical Devices/Bundesinstituts
192   IV,    12. 10       |       Guidelines are being published.~Drugs and substance abuse~High~
193   IV,    12. 10       |             abuse~High~ The Misuse of Drugs Act 1977 and the Regulations
194   IV,    12. 10       |               range of named narcotic drugs and psychotropic substances
195   IV,    12. 10       |             by the~Local and Regional Drugs Task Forces.~Local and Regional
196   IV,    12. 10       |            Forces.~Local and Regional Drugs Task Forces~which are partnerships
197   IV,    12. 10       |              High~In line with the EU Drugs Action Plan~developments
198   IV,    12. 10       |        National Advisory Committee on Drugs~(NACD) Report An Overview
199   IV,    12. 10       |                cocaine and prescribed~drugs). The HSE is up-skilling
200   IV,    12. 10       |               of the working~group on Drugs Rehabilitation was~published
201   IV,    12. 10       |        National Advisory Committee~on Drugs in September 2007 published~
202   IV,    12. 10       |                Main campaign programs~Drugs and substance abuse~ High~ ~ ~
203   IV,    12. 10       |             health nutrition programs~Drugs and substance abuse~ high~
204   IV,    12. 10       |         places for reducing risks for drugs users~2007: inside prevention
205   IV,    12. 10       |            and awareness training for drugs users~ Permanent campaign
206   IV,    12. 10       |              stiliVita/stiliVita.jsp)~Drugs and substance abuse~ High~
207   IV,    12. 10       |            Pharmaceuticals~ ~National Drugs Agency (Agenzia Italiana
208   IV,    12. 10       |              harmonisation~ ~National Drugs Agency (Agenzia Italiana
209   IV,    12. 10       |           Reducing harm from alcohol, drugs and tobacco” in national
210   IV,    12. 10       |           Reducing harm from alcohol, drugs and tobacco” in national
211   IV,    12. 10       |              Public Health Strategy~ ~Drugs and substance abuse~intermediate~
212   IV,    12. 10       |           Reducing harm from alcohol, drugs and tobacco” in national
213   IV,    12. 10       |         Health Determinants Programme~Drugs and substance abuse~ High~
214   IV,    12. 10       |             health nutrition programs~Drugs and substance abuse~ High~
215   IV,    12. 10       |               use of alcohol, illicit drugs and smoking. As part of
216   IV,    12. 10       |     Agriculture policy~Use of illicit drugs~Self-reported use of illicit
217   IV,    12. 10       |          Self-reported use of illicit drugs~ ~Mortality~Domain of objective
218   IV,    12. 10       |             society free from illicit drugs and doping, and a reduction
219   IV,    12. 10       |               level~ Local programmes~Drugs and substance abuse~ High~
220   IV,    13.  2.  4   |               refraining from illicit drugs and unsafe sex would lessen
221  Key,   Ap5.  0.  0   |           drug-induced~drug-resistant~drugs~duchenne~dust~dust-mite~